Synthetic biology for translational research

American Journal of Translational Research

Volumn 2, Issue 4, 2010, Pages 381-389

  Burbelo, Peter D ^a   Ching, Kathryn H ^a   Han, Brian L ^a   Klimavicz, Caitlin M ^a   Iadarola, Michael J ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Artificial gene synthesis; Drug discovery; Genetically modified organisms; Synthetic biology; Translational research; Vaccines

Indexed keywords

2 PHENYLETHYL BUTYRATE; ARTEMISIN; CHIMERIC PROTEIN; EPITOPE; ETHIONAMIDE; INFLUENZA VACCINE; INVASIN; NATURAL PRODUCT; ONCOLYTIC VIRUS; PACLITAXEL; UNCLASSIFIED DRUG; VMP 001 PROTEIN;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIBIOTIC RESISTANCE; ARTIFICIAL GENE SYNTHESIS; AUTOIMMUNE DISEASE; BACTERIAL GENE; BACTERIOPHAGE; BIOENGINEERING; BIOSYNTHESIS; CANCER THERAPY; DIAGNOSTIC PROCEDURE; DISEASE CONTROL; DNA TEMPLATE; DRUG DESIGN; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG SCREENING; GENE SYNTHESIS; GENE TRANSFER; GENETIC ENGINEERING; GENETIC RECOMBINATION; HUMAN; IMMUNOASSAY; INFLUENZA A (H5N1); INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; MEDICAL RESEARCH; MICROORGANISM; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA GENITALIUM; MYCOPLASMA MYCOIDES; NONHUMAN; ONCOLYTIC VIROTHERAPY; PLASMODIUM VIVAX; POLIOMYELITIS VIRUS; REVIEW; SARS CORONAVIRUS; SERODIAGNOSIS; SPANISH INFLUENZA VIRUS; SYNTHETIC BIOLOGY; TAXUS BREVIFOLIA; TRANSGENIC ORGANISM; TRANSLATIONAL RESEARCH; VACCINE PRODUCTION; VIROGENESIS; VIRUS ATTENUATION; VIRUS RECOMBINANT; YERSINIA PSEUDOTUBERCULOSIS;

EID: 77957345403     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Cuccato G, Della Gatta G, di Bernardo D: Systems and Synthetic biology: tackling genetic networks and complex diseases. Heredity 2009; 102: 527-532.
2. Khalil AS, Collins JJ: Synthetic biology: applications come of age. Nat Rev Genet 2010, 11: 367-379.
3. Mueller S, Coleman JR, Wimmer E: Putting synthesis into biology: a viral view of genetic engineering through de novo gene and genome synthesis. Chem Biol 2009; 16: 337-347.
4. Gibson DG, Glass JI, Lartigue C, Noskov VN, Chuang RY, Algire MA, Benders GA, Montague MG, Ma L, Moodie MM, et al: Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome. Science 2010; 329: 52-56.
5. Wang D, Coscoy L, Zylberberg M, Avila PC, Boushey HA, Ganem D, DeRisi JL: Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A 2002; 99: 15687-15692.
6. Burbelo PD, Leahy HP, Iadarola MJ, Nutman TB: A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl Trop Dis 2009; 3: e438.
7. Ramanathan R, Burbelo PD, Groot S, Iadarola MJ, Neva FA, Nutman TB: A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection. J Infect Dis 2008; 198: 444-451.
8. Burbelo PD, Issa AT, Ching KH, Cohen JI, Iadarola MJ, Marques A: Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease. Clin Vaccine Immunol 2010; 17: 904-909.
9. Burbelo PD, Ching KH, Bush ER, Han BL, Iadarola MJ: Antibody-profiling technologies for studying humoral responses to infectious agents. Expert Rev Vaccines 2010; 9: 567-578.
10. Delwart EL: Viral metagenomics. Rev Med Virol 2007; 17: 115-131.
11. Feng H, Shuda M, Chang Y, Moore PS: Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-1100.
12. Carter JJ, Paulson KG, Wipf GC, Miranda D, Madeleine MM, Johnson LG, Lemos BD, Lee S, Warcola AH, Iyer JG, et al: Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009; 101: 1510-1522.
13. Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, Moschos S, Chang Y, Buck CB, Moore PS: Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 2009; 125: 1250-1256.
14. Cello J, Paul AV, Wimmer E: Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 2002; 297: 1016-1018.
15. Smith HO, Hutchison CA, 3rd, Pfannkoch C, Venter JC: Generating a synthetic genome by whole genome assembly: phiX174 bacteriophage from synthetic oligonucleotides. Proc Natl Acad Sci U S A 2003; 100: 15440-15445.
16. Tumpey TM, Maines TR, Van Hoeven N, Glaser L, Solorzano A, Pappas C, Cox NJ, Swayne DE, Palese P, Katz JM, Garcia-Sastre A: A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 2007; 315: 655-659.
17. Becker MM, Graham RL, Donaldson EF, Rockx B, Sims AC, Sheahan T, Pickles RJ, Corti D, Johnston RE, Baric RS, Denison MR: Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc Natl Acad Sci U S A 2008; 105: 19944-19949.
18. Gibson DG, Benders GA, Andrews-Pfannkoch C, Denisova EA, Baden-Tillson H, Zaveri J, Stockwell TB, Brownley A, Thomas DW, Algire MA, et al: Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science 2008; 319: 1215-1220.
19. Yadava A, Sattabongkot J, Washington MA, Ware LA, Majam V, Zheng H, Kumar S, Ockenhouse CF: A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites. Infect Immun 2007; 75: 1177-1185.
20. Chen MW, Cheng TJ, Huang Y, Jan JT, Ma SH, Yu AL, Wong CH, Ho DD: A consensushemagglutinin- based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci U S A 2008; 105: 13538-13543.
21. Coleman JR, Papamichail D, Skiena S, Futcher B, Wimmer E, Mueller S: Virus attenuation by genome-scale changes in codon pair bias. Science 2008; 320: 1784-1787.
22. Mueller S, Coleman JR, Papamichail D, Ward CB, Nimnual A, Futcher B, Skiena S, Wimmer E: Live attenuated influenza virus vaccines by computer-aided rational design. Nat Biotechnol 2010.
23. Weber W, Schoenmakers R, Keller B, Gitzinger M, Grau T, Daoud-El Baba M, Sander P, Fussenegger M: A synthetic mammalian gene circuit reveals antituberculosis compounds. Proc Natl Acad Sci U S A 2008; 105: 9994-9998.
24. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, et al: Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006; 440: 940-943.
25. Brady SF: Construction of soil environmental DNA cosmid libraries and screening for clones that produce biologically active small molecules. Nat Protoc 2007; 2: 1297-1305.
26. Lu TK, Collins JJ: Dispersing biofilms with engineered enzymatic bacteriophage. Proc Natl Acad Sci U S A 2007; 104: 11197-11202.
27. Lu TK, Collins JJ: Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci U S A 2009; 106: 4629-4634.
28. Anderson JC, Clarke EJ, Arkin AP, Voigt CA: Environmentally controlled invasion of cancer cells by engineered bacteria. J Mol Biol 2006; 355: 619-627.
29. Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B: Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A 2001; 98: 15155-15160.
30. Agrawal N, Bettegowda C, Cheong I, Geschwind JF, Drake CG, Hipkiss EL, Tatsumi M, Dang LH, Diaz LA, Jr., Pomper M, et al: Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A 2004; 101: 15172-15177.